Fresenius Kabi
The Senior Manager, Patient Support Program (Vigilance) is responsible for overseeing pharmacovigilance activities supporting the Biosimilars portfolio within FDA regulations. The role involves developing standards, managing data exchange agreements, overseeing risk mitigation programs, and ensuring regulatory compliance across global and local procedures. It requires collaboration with multiple departments and external partners to maintain a compliant and effective vigilance program.
Fresenius Kabi is a global healthcare company specializing in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The company develops, manufactures, and markets generic IV drugs, biosimilars, medical devices, and nutrition products used in hospitals and outpatient care. Fresenius Kabi operates in the pharmaceutical and medical technology industry, serving healthcare providers and patients worldwide.
Fresenius Kabi recalls Ivenix infusion pumps over software problem
1 week ago
Fresenius Kabi Recognized as a Top Employer in the United States for the Fourth Consecutive Year
1 month ago
Fresenius Kabi, Phlow ink US onshoring alliance to boost epinephrine injection supply
1 month ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Fresenius Kabi.
Fresenius Kabi Receives 2025 Premier Supplier Legacy Award
Jul 17, 2025
Principal, Pharmacovigilance / Device Vigilance
Jobgether
Sr Mgr Regulatory Compliance - Medical Events, Vigilance & AE Case Reporting
medlineindustrieslp.com
Senior Director of Vigilance and FDA Compliance
Fresenius Kabi
Alternant(e) Compliance Vigilance
Novocol Pharma
Senior Director, Drug Safety Operations
Centessa Pharmaceuticals
Manager, Drug Safety
DKSH